IS Pharma
Stage
Unattributed | AliveTotal Raised
$5.7MLast Raised
$5.7M | 12 yrs agoAbout IS Pharma
S Pharma (International Speciality Pharmaceuticals) is a fast growing, profitable business which develops, acquires and commercialises late-stage pharmaceuticals and medical devices, focusing in critical care, oncology and neurology. Based in the UK, IS Pharma commercialises its portfolio in the UK directly and internationally through a strong network of distributors.
Missing: IS Pharma's Product Demo & Case Studies
Promote your product offering to tech buyers.
Reach 1000s of buyers who use CB Insights to identify vendors, demo products, and make purchasing decisions.
Missing: IS Pharma's Product & Differentiators
Don’t let your products get skipped. Buyers use our vendor rankings to shortlist companies and drive requests for proposals (RFPs).
Expert Collections containing IS Pharma
Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.
IS Pharma is included in 1 Expert Collection, including Cancer.
Cancer
3,605 items
Companies researching, developing, or offering products & services that aid in the screening, prevention, diagnosis, management, and treatment of cancer.
IS Pharma Patents
IS Pharma has filed 1 patent.

Application Date | Grant Date | Title | Related Topics | Status |
---|---|---|---|---|
6/4/2010 | 6/11/2013 | Colloidal chemistry, Chromatography, Dosage forms, Solvents, Drug delivery devices | Grant |
Application Date | 6/4/2010 |
---|---|
Grant Date | 6/11/2013 |
Title | |
Related Topics | Colloidal chemistry, Chromatography, Dosage forms, Solvents, Drug delivery devices |
Status | Grant |
Latest IS Pharma News
Nov 23, 2022
Search jobs 6th December | 1pm | Royal Society of Medicine The PM Society is excited to announce that their Learning & Development Interest Group will be hosting their inaugural seminar on the 6th December 2022 in London. The Learning & Development Interest Group spent the summer of 2022 interviewing an array of pharmaceutical marketeers, at all levels. Our focus was to determine what are the key issues that marketeers continue to struggle with and seek learning and development support for in their companies. We found four clear areas, which our seminar will explore Using customer understanding to inform true customer centricity – PMs told us that they struggle to commission, utilise and apply customer insight gathering to their brands successfully Joined up omnichannel strategy – despite huge amounts of activity PMs are concerned that there is a focus on the number of channels vs harnessing channels to deliver change The Red Thread – very often PMs stated that planning processes and templates can sever the red thread from customer insight to strategy to tactic Moving up – PMs stated that when promoted to lead marketing/brands, their strategic marketing skills have been long forgotten We have lined up a fantastic faculty of speakers and panelists, who will consider these issues and offer solutions and learning and development ideas to help marketeers resolve these issues. Read the full agenda here . So if any of the issues above sound familiar to you, as a pharmaceutical marketeer, as an L&D professional or you are considering moving to marketing, then this seminar is for you. Tickets are selling fast, so book now to avoid disappointment. This seminar may help you in your role in 2023. We look forward to welcoming you and your team to our event on the 6th December The PM Society is a not-for-profit organisation that believes excellent healthcare communications leads to better outcomes for patients. The PM Society has the following purpose: Supporting organisations and people in healthcare Recognising excellence and promoting best practice Providing education and development The PM Society was established over 40 years ago to serve the needs of the pharmaceutical industry and its service agencies. It currently has over 230 companies as members, including pharma and biotech companies on the industry side and PR, Advertising, Medical Communications, Digital and many other kinds of service company on the agency side Editor Details
IS Pharma Frequently Asked Questions (FAQ)
What is IS Pharma's latest funding round?
IS Pharma's latest funding round is Unattributed.
How much did IS Pharma raise?
IS Pharma raised a total of $5.7M.
Who are the investors of IS Pharma?
Investors of IS Pharma include Abingworth.
Discover the right solution for your team
The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.